Europe's Biotechs Gathering Steam With Filgotinib Filing

 
• By John Davis

Galapagos is another step closer to commercializing its products with its lead candidate, filgotinib, now under the gaze of EU regulators.

Engine
Getting a drug to market is a complex business • Source: Shutterstock

More from New Products

More from Scrip